Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.
Identifieur interne : 000872 ( PubMed/Curation ); précédent : 000871; suivant : 000873Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.
Auteurs : Leigh Christopher [Canada] ; Antonio P. StrafellaSource :
- Journal of neuropsychology [ 1748-6653 ] ; 2013.
English descriptors
- KwdEn :
- Brain (diagnostic imaging), Brain (pathology), Brain (physiopathology), Cognition Disorders (complications), Cognition Disorders (diagnostic imaging), Cognition Disorders (pathology), Cognition Disorders (physiopathology), Humans, Nerve Fibers, Myelinated (pathology), Nerve Fibers, Unmyelinated (pathology), Neural Pathways (pathology), Neural Pathways (physiopathology), Neuroimaging, Parkinson Disease (complications), Parkinson Disease (diagnostic imaging), Parkinson Disease (pathology), Parkinson Disease (physiopathology), Radionuclide Imaging.
- MESH :
- complications : Cognition Disorders, Parkinson Disease.
- diagnostic imaging : Brain, Cognition Disorders, Parkinson Disease.
- pathology : Brain, Cognition Disorders, Nerve Fibers, Myelinated, Nerve Fibers, Unmyelinated, Neural Pathways, Parkinson Disease.
- physiopathology : Brain, Cognition Disorders, Neural Pathways, Parkinson Disease.
- Humans, Neuroimaging, Radionuclide Imaging.
Abstract
Cognitive impairment occurs frequently in Parkinson's disease (PD) and the concept of Mild Cognitive Impairment in PD (PD-MCI) has recently emerged. Patients with mild impairment are at risk of developing dementia, and thus it is a topic of growing interest. Many previous studies have investigated the neural correlates of cognitive impairment, in particular executive dysfunction, in PD patients without dementia using neuroimaging techniques including structural MRI, functional MRI and PET imaging. These studies, which have provided a foundation for understanding which brain regions and neurotransmitter systems may be involved in executive dysfunction in PD, will be reviewed. Recent neuroimaging studies that have used specific criteria to classify patients as PD-MCI, in the hopes of gaining further insight into the underlying neural mechanisms will also be discussed. In particular, this review will cover key findings involving structural MRI investigating grey and white matter changes, functional MRI to examine changes in neural activation and PET imaging to investigate metabolic and neurochemical changes that have led to an improved understanding of pathology associated with executive dysfunction in PD without dementia and PD-MCI.
DOI: 10.1111/jnp.12015
PubMed: 23551844
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000872
Links to Exploration step
pubmed:23551844Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.</title><author><name sortKey="Christopher, Leigh" sort="Christopher, Leigh" uniqKey="Christopher L" first="Leigh" last="Christopher">Leigh Christopher</name><affiliation wicri:level="1"><nlm:affiliation>Division of Brain, Imaging and Behaviour--Systems Neuroscience, Toronto Western Research Institute, UHN, University of Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Brain, Imaging and Behaviour--Systems Neuroscience, Toronto Western Research Institute, UHN, University of Toronto, Ontario</wicri:regionArea></affiliation></author><author><name sortKey="Strafella, Antonio P" sort="Strafella, Antonio P" uniqKey="Strafella A" first="Antonio P" last="Strafella">Antonio P. Strafella</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23551844</idno><idno type="pmid">23551844</idno><idno type="doi">10.1111/jnp.12015</idno><idno type="wicri:Area/PubMed/Corpus">000872</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000872</idno><idno type="wicri:Area/PubMed/Curation">000872</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000872</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.</title><author><name sortKey="Christopher, Leigh" sort="Christopher, Leigh" uniqKey="Christopher L" first="Leigh" last="Christopher">Leigh Christopher</name><affiliation wicri:level="1"><nlm:affiliation>Division of Brain, Imaging and Behaviour--Systems Neuroscience, Toronto Western Research Institute, UHN, University of Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Brain, Imaging and Behaviour--Systems Neuroscience, Toronto Western Research Institute, UHN, University of Toronto, Ontario</wicri:regionArea></affiliation></author><author><name sortKey="Strafella, Antonio P" sort="Strafella, Antonio P" uniqKey="Strafella A" first="Antonio P" last="Strafella">Antonio P. Strafella</name></author></analytic><series><title level="j">Journal of neuropsychology</title><idno type="eISSN">1748-6653</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Brain (diagnostic imaging)</term><term>Brain (pathology)</term><term>Brain (physiopathology)</term><term>Cognition Disorders (complications)</term><term>Cognition Disorders (diagnostic imaging)</term><term>Cognition Disorders (pathology)</term><term>Cognition Disorders (physiopathology)</term><term>Humans</term><term>Nerve Fibers, Myelinated (pathology)</term><term>Nerve Fibers, Unmyelinated (pathology)</term><term>Neural Pathways (pathology)</term><term>Neural Pathways (physiopathology)</term><term>Neuroimaging</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (diagnostic imaging)</term><term>Parkinson Disease (pathology)</term><term>Parkinson Disease (physiopathology)</term><term>Radionuclide Imaging</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Cognition Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Brain</term><term>Cognition Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term><term>Cognition Disorders</term><term>Nerve Fibers, Myelinated</term><term>Nerve Fibers, Unmyelinated</term><term>Neural Pathways</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Brain</term><term>Cognition Disorders</term><term>Neural Pathways</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Neuroimaging</term><term>Radionuclide Imaging</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Cognitive impairment occurs frequently in Parkinson's disease (PD) and the concept of Mild Cognitive Impairment in PD (PD-MCI) has recently emerged. Patients with mild impairment are at risk of developing dementia, and thus it is a topic of growing interest. Many previous studies have investigated the neural correlates of cognitive impairment, in particular executive dysfunction, in PD patients without dementia using neuroimaging techniques including structural MRI, functional MRI and PET imaging. These studies, which have provided a foundation for understanding which brain regions and neurotransmitter systems may be involved in executive dysfunction in PD, will be reviewed. Recent neuroimaging studies that have used specific criteria to classify patients as PD-MCI, in the hopes of gaining further insight into the underlying neural mechanisms will also be discussed. In particular, this review will cover key findings involving structural MRI investigating grey and white matter changes, functional MRI to examine changes in neural activation and PET imaging to investigate metabolic and neurochemical changes that have led to an improved understanding of pathology associated with executive dysfunction in PD without dementia and PD-MCI.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23551844</PMID><DateCreated><Year>2013</Year><Month>09</Month><Day>06</Day></DateCreated><DateCompleted><Year>2014</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1748-6653</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>2</Issue><PubDate><Year>2013</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of neuropsychology</Title><ISOAbbreviation>J Neuropsychol</ISOAbbreviation></Journal><ArticleTitle>Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.</ArticleTitle><Pagination><MedlinePgn>225-40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jnp.12015</ELocationID><Abstract><AbstractText>Cognitive impairment occurs frequently in Parkinson's disease (PD) and the concept of Mild Cognitive Impairment in PD (PD-MCI) has recently emerged. Patients with mild impairment are at risk of developing dementia, and thus it is a topic of growing interest. Many previous studies have investigated the neural correlates of cognitive impairment, in particular executive dysfunction, in PD patients without dementia using neuroimaging techniques including structural MRI, functional MRI and PET imaging. These studies, which have provided a foundation for understanding which brain regions and neurotransmitter systems may be involved in executive dysfunction in PD, will be reviewed. Recent neuroimaging studies that have used specific criteria to classify patients as PD-MCI, in the hopes of gaining further insight into the underlying neural mechanisms will also be discussed. In particular, this review will cover key findings involving structural MRI investigating grey and white matter changes, functional MRI to examine changes in neural activation and PET imaging to investigate metabolic and neurochemical changes that have led to an improved understanding of pathology associated with executive dysfunction in PD without dementia and PD-MCI.</AbstractText><CopyrightInformation>© 2013 The British Psychological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Christopher</LastName><ForeName>Leigh</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Brain, Imaging and Behaviour--Systems Neuroscience, Toronto Western Research Institute, UHN, University of Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strafella</LastName><ForeName>Antonio P</ForeName><Initials>AP</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>110962-1</GrantID><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant><Grant><GrantID>MOP 110962</GrantID><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neuropsychol</MedlineTA><NlmUniqueID>101468753</NlmUniqueID><ISSNLinking>1748-6645</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2007 Mar;78(3):254-9</RefSource><PMID Version="1">17028119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2007 May 2;27(18):4832-8</RefSource><PMID Version="1">17475791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2007 Jul;130(Pt 7):1787-98</RefSource><PMID Version="1">17535834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 1998 May;121 ( Pt 5):949-65</RefSource><PMID Version="1">9619196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 1999 Jan;56(1):33-9</RefSource><PMID Version="1">9923759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 1999 Mar;56(3):303-8</RefSource><PMID Version="1">10190820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Geriatr Psychiatry. 1999 Oct;14(10):866-74</RefSource><PMID Version="1">10521886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2005 Jan 25;64(2):224-9</RefSource><PMID Version="1">15668417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Aging. 2005 Jun;26(6):891-8</RefSource><PMID Version="1">15718048</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2005 Mar 9;25(10):2471-7</RefSource><PMID Version="1">15758155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2005 Jun;128(Pt 6):1314-22</RefSource><PMID Version="1">15716302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Geriatr Psychiatry Neurol. 2005 Sep;18(3):149-54</RefSource><PMID Version="1">16100104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1204-10</RefSource><PMID Version="1">16107352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurosci Biobehav Rev. 2006;30(1):1-23</RefSource><PMID Version="1">15935475</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol. 2006 Feb;253(2):242-7</RefSource><PMID Version="1">16133720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Neurol. 2006 Mar;5(3):235-45</RefSource><PMID Version="1">16488379</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 2006;44(10):1663-73</RefSource><PMID Version="1">16730032</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2006 Sep;21(9):1343-9</RefSource><PMID Version="1">16721732</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroimage. 2006 Nov 15;33(3):907-12</RefSource><PMID Version="1">16982202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroimage. 2007 Jan 15;34(2):714-23</RefSource><PMID Version="1">17113310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2007 Jan;130(Pt 1):233-44</RefSource><PMID Version="1">17121746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2012 Mar;27(3):349-56</RefSource><PMID Version="1">22275317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cereb Blood Flow Metab. 2012 Aug;32(8):1609-17</RefSource><PMID Version="1">22569194</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Brain Mapp. 2013 Jul;34(7):1591-604</RefSource><PMID Version="1">22331665</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 2000;38(5):596-612</RefSource><PMID Version="1">10689037</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Geriatr Soc. 2000 Aug;48(8):938-42</RefSource><PMID Version="1">10968298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Neurol Scand. 2007 Aug;116(2):108-12</RefSource><PMID Version="1">17661796</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2007 Jul 15;22(9):1272-7</RefSource><PMID Version="1">17415797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837</RefSource><PMID Version="1">17542011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2008 Feb;131(Pt 2):397-408</RefSource><PMID Version="1">18178571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2008 Apr 15;70(16 Pt 2):1470-7</RefSource><PMID Version="1">18367705</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2008 Apr 30;23(6):837-44</RefSource><PMID Version="1">18307261</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2008 May;131(Pt 5):1294-302</RefSource><PMID Version="1">18362097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychiatry Res. 2008 Jul 15;163(2):171-82</RefSource><PMID Version="1">18504119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2008 Sep 15;23(12):1776-80</RefSource><PMID Version="1">18661545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2008 Dec;79(12):1331-8</RefSource><PMID Version="1">18653550</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2009 Jan 30;24(2):277-82</RefSource><PMID Version="1">19025777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2009 Mar;15(3):187-95</RefSource><PMID Version="1">18573676</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2009 Apr 15;29(15):4690-6</RefSource><PMID Version="1">19369539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroimage. 2009 Jun;46(2):516-21</RefSource><PMID Version="1">19264140</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol. 2009 Aug;256 Suppl 3:293-8</RefSource><PMID Version="1">19711119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2009 Nov;132(Pt 11):2958-69</RefSource><PMID Version="1">19812213</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Aging. 2010 Jun;31(6):1064-8</RefSource><PMID Version="1">18755526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2010 Apr 30;25(6):687-95</RefSource><PMID Version="1">20437538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Neurol. 2010;64(2):65-73</RefSource><PMID Version="1">20606450</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2010 Dec;16(10):666-70</RefSource><PMID Version="1">20870446</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Nucl Med. 2011 Jun;52(6):848-55</RefSource><PMID Version="1">21571793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 2011 Dec;68(12):1562-8</RefSource><PMID Version="1">22159053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2011 Aug 15;26(10):1814-24</RefSource><PMID Version="1">21661055</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2012 Jan;135(Pt 1):170-80</RefSource><PMID Version="1">22108576</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Brain Mapp. 2012 Mar;33(3):727-39</RefSource><PMID Version="1">21495116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 2003 Dec;60(12):1745-8</RefSource><PMID Version="1">14676050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2004 Jan 21;24(3):702-10</RefSource><PMID Version="1">14736856</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2004 Mar;127(Pt 3):550-60</RefSource><PMID Version="1">14691062</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2004 Apr;127(Pt 4):791-800</RefSource><PMID Version="1">14749292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Geriatr Soc. 2004 May;52(5):784-8</RefSource><PMID Version="1">15086662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol. 2004 Jul;251(7):795-804</RefSource><PMID Version="1">15258780</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2004 Oct;75(10):1467-9</RefSource><PMID Version="1">15377698</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Sci. 1983 May;59(2):277-89</RefSource><PMID Version="1">6854353</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 1983 Sep 26;275(2):321-8</RefSource><PMID Version="1">6626985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 1986 Oct;109 ( Pt 5):845-83</RefSource><PMID Version="1">3779372</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1988 Apr 7;318(14):876-80</RefSource><PMID Version="1">3352672</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 1989;27(11-12):1329-43</RefSource><PMID Version="1">2615934</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 1990 Feb 26;510(1):104-7</RefSource><PMID Version="1">1691042</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1994 Mar;57(3):360-7</RefSource><PMID Version="1">8158188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fortschr Med. 1997 May 20;115(14):45-8</RefSource><PMID Version="1">9264971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 1998 May;121 ( Pt 5):815-42</RefSource><PMID Version="1">9619187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2001 May;124(Pt 5):1020-32</RefSource><PMID Version="1">11335704</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurosci Lett. 2001 Sep 28;311(2):81-4</RefSource><PMID Version="1">11567783</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cereb Cortex. 2001 Dec;11(12):1136-43</RefSource><PMID Version="1">11709484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 2002 Feb;51(2):156-64</RefSource><PMID Version="1">11835371</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2002 Mar;125(Pt 3):584-94</RefSource><PMID Version="1">11872615</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2002 Jun;125(Pt 6):1358-65</RefSource><PMID Version="1">12023324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dement Geriatr Cogn Disord. 2003;15(3):126-31</RefSource><PMID Version="1">12584427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 2003;41(6):645-54</RefSource><PMID Version="1">12591022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 2003 Mar;60(3):387-92</RefSource><PMID Version="1">12633150</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2003 Jul 16;23(15):6351-6</RefSource><PMID Version="1">12867520</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009413" MajorTopicYN="N">Nerve Fibers, Myelinated</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036421" MajorTopicYN="N">Nerve Fibers, Unmyelinated</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009434" MajorTopicYN="N">Neural Pathways</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="Y">Neuroimaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011877" MajorTopicYN="N">Radionuclide Imaging</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">CAMS4597</OtherID><OtherID Source="NLM">PMC4452222</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>07</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>02</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23551844</ArticleId><ArticleId IdType="doi">10.1111/jnp.12015</ArticleId><ArticleId IdType="pmc">PMC4452222</ArticleId><ArticleId IdType="mid">CAMS4597</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000872 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000872 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:23551844
|texte= Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:23551844" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |